Language selection

Search

Details for: NEXIUM

Company: ASTRAZENECA CANADA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02300524NEXIUMESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)10 MG / SACHETGRANULES FOR SUSPENSION, DELAYED RELEASEORAL
02244521NEXIUM - 20MGESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)20 MGTABLET (DELAYED-RELEASE)ORAL
02244522NEXIUM - 40MGESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)40 MGTABLET (DELAYED-RELEASE)ORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Proton Pump Inhibitors - Assessing the Potential Risk of Clostridium difficile Infection
Summary Safety Review - Proton Pump Inhibitors (PPIs) - Assessing the risk of a type of skin reaction [Subacute Cutaneous Lupus Erythematosus (SCLE)]

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: